2005年3月第5期
·07/05/08 Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
·07/05/08 The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential
·07/05/08 Prospective isolation and global gene expression analysis of the erythrocyte colony-forming unit (CFU-E)
·07/05/08 A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain
·07/05/08 Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase
·07/05/08 Platelet depletion by anti-CD41 (IIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines
·07/05/08 Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-2 glycoprotein I antibodies
·07/05/08 Inhibition of vascular endothelial growth factor receptor 2–mediated endothelial cell activation by Axl tyrosine kinase receptor
·07/05/08 The platelet glycoprotein Ib–von Willebrand factor interaction activates the collagen receptor 21 to bind collagen: activation-dependent conformational change of the 2-I domain
·07/05/08 Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2
·07/05/08 High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells
·07/05/08 Punish the parent not the progeny
·07/05/08 Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells
·07/05/08 Induction of BCR-ABL–specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells
·07/05/08 Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease
·07/05/08 Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I
·07/05/08 ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia
·07/05/08 Membrane receptors are not required to deliver granzyme B during killer cell attack
·07/05/08 Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen
·07/05/08 TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
·07/05/08 Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation
·07/05/08 Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD15
·07/05/08 Iron trafficking in the mitochondrion: novel pathways revealed by disease
·07/05/08 Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes
·07/05/08 Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
·07/05/08 Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine
·07/05/08 RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
·07/05/08 Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
·07/05/08 Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
·07/05/08 Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
·07/05/08 Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma
·07/05/08 Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells
·07/05/08 High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia
·07/05/08 Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma
·07/05/08 Liver Kupffer cells rapidly remove red blood cell–derived vesicles from the circulation by scavenger receptors
·07/05/08 The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential
·07/05/08 Prospective isolation and global gene expression analysis of the erythrocyte colony-forming unit (CFU-E)
·07/05/08 A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain
·07/05/08 Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase
·07/05/08 Platelet depletion by anti-CD41 (IIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines
·07/05/08 Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-2 glycoprotein I antibodies
·07/05/08 Inhibition of vascular endothelial growth factor receptor 2–mediated endothelial cell activation by Axl tyrosine kinase receptor
·07/05/08 The platelet glycoprotein Ib–von Willebrand factor interaction activates the collagen receptor 21 to bind collagen: activation-dependent conformational change of the 2-I domain
·07/05/08 Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2
·07/05/08 High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells
·07/05/08 Punish the parent not the progeny
·07/05/08 Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells
·07/05/08 Induction of BCR-ABL–specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells
·07/05/08 Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease
·07/05/08 Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I
·07/05/08 ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia
·07/05/08 Membrane receptors are not required to deliver granzyme B during killer cell attack
·07/05/08 Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen
·07/05/08 TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
·07/05/08 Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation
·07/05/08 Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD15
·07/05/08 Iron trafficking in the mitochondrion: novel pathways revealed by disease
·07/05/08 Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes
·07/05/08 Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
·07/05/08 Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine
·07/05/08 RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
·07/05/08 Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
·07/05/08 Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
·07/05/08 Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
·07/05/08 Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma
·07/05/08 Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells
·07/05/08 High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia
·07/05/08 Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma
·07/05/08 Liver Kupffer cells rapidly remove red blood cell–derived vesicles from the circulation by scavenger receptors
栏目列表
·2005年7月第13期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期